UNSPSC 41202001: Acinetobacter calcoaceticusserological reagents

In this classification, Acinetobacter calcoaceticus serological reagents are devices used in test to identify specific Acinetobacter calcoaceticus antibodies in serum. US FDA regulates Acinetobacter calcoaceticus serological reagents under 21 CFR 866.3010 and under FDA product code GSX.

UNSPSC 41202001 Acinetobacter calcoaceticusserological reagents is a Commodity code that covers diagnostic reagents and supplies for infectious-disease testing — specifically serological testing kits, controls, calibrators, and related consumables used by state and local public health laboratories, correctional health systems, and municipal health departments. State and local governments actually procure HIV, syphilis, and sexually transmitted infection (STI) testing reagents under this code, along with the associated controls and calibrators required to maintain CLIA compliance and analyzer functionality. The issuing bodies soliciting under this code span state health departments (Illinois Department of Public Health), county health services (Collin County Health Care Services, Gwinnett County), city public health programs (City of Austin), county criminal-justice supervision systems (Collin County Community Supervision and Corrections Department), and state criminal-justice agencies (Texas Department of Criminal Justice). Illinois Department of Public Health appears as a repeat buyer, conducting both emergency sole-source procurements and competitive solicitations for Abbott reagent systems.

Recent activity concentrates in Texas, Illinois, and Georgia. Representative recent opportunities include the Illinois Department of Public Health's change order (27482DPHOFCDIB53956, IFB, response due October 13, 2026) to increase STI test volumes under its existing Hologic Panther NAAT platform rental agreement from 15,000 to 25,000 NG/CT tests annually and from 15,000 to 30,000 collection kits annually, increasing total contract cost by $375,000 to $900,000 over five years; the City of Austin's rebid for rapid HIV Type 1 and Type 2 test kits (IFB 9100AAM1023REBID, response due September 3, 2026) for approximately 375 Abbott Determine test kits and 79 control kits annually; and Collin County Community Supervision and Corrections Department's RFP for offender specimen collection and drug testing services (2026-327, response due July 23, 2026) covering approximately 25,031 tests annually with SAMHSA or CAP lab certification required and an estimated contract value of $600,000. Emergency and sole-source awards to Abbott Laboratories Inc. by Illinois IDPH indicate established infrastructure dependencies and procurement urgency around maintaining CLIA certification and testing continuity.